The European Commission granted marketing approval for Vitrasert Implant to treat cytomegalovirus (CMV) retinitis in AIDS patients. The product releases Hoffmann-La Roche's ganciclovir antiviral agent directly to the eye. The product was recommended for approval in Europe in November. ...
